Leisure Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LACQU and buy or sell other stocks, ETFs, and their options commission-free!About LACQU
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees9
Employees9
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees9
Employees9
LACQU Key Statistics
Market cap40.56M
Market cap40.56M
Price-Earnings ratio28.40
Price-Earnings ratio28.40
Dividend yield—
Dividend yield—
Average volume25.10
Average volume25.10
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$22.01
52 Week high$22.01
52 Week low$9.03
52 Week low$9.03
Stock Snapshot
The current Leisure Acquisition(LACQU) stock price is $12.75, with a market capitalization of 40.56M. The stock trades at a price-to-earnings (P/E) ratio of 28.40.
On 2025-12-17, Leisure Acquisition(LACQU) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Leisure Acquisition(LACQU) stock has reached 0, versus its average volume of 25.1.
Over the past 52 weeks, Leisure Acquisition(LACQU) stock has traded between a high of $22.01 and a low of $9.03.
Over the past 52 weeks, Leisure Acquisition(LACQU) stock has traded between a high of $22.01 and a low of $9.03.